Literature DB >> 22398863

Significance of lymph node micrometastasis in pancreatic cancer patients.

J Kaťuchová1, J Bober, V Kaťuch, J Radoňak.   

Abstract

UNLABELLED: BACKGROUND /AIMS: The present study deals with the significance of lymph node micrometastasis in the survival rate for pancreatic cancer patients.
METHODS: Between January 2006 and December 2010 at the First Department of Surgery in Košice, a prospective trial was done in which we investigated the survival rate after radical pancreatic resection. All negative lymph nodes removed during standard radical lymphadenectomy were subjected to immunohistochemical staining to detect occult micrometastasis. A comparison of the median survival rate in groups of patients with immunohistochemistry-positive and -negative lymph nodes was performed.
RESULTS: Radical pancreatic resection with standard radical lymphadenectomy was performed on 64 pancreatic cancer patients. The median survival time was 15 months. Out of the 319 histopathologically negative lymph nodes (34 patients), 134 lymph nodes were classified as immunohistochemistry positive (21 patients). The median survival rate in the group of patients with immunohistochemistry-negative lymph nodes was 23 months, but in the group of patients with immunohistochemistry-positive lymph nodes it was 14 months. There was a statistically significant difference between these 2 groups of patients (p ≤ 0.01).
CONCLUSION: The immunohistochemical examination of histopathologically negative lymph nodes can lead to positive lymph node detection. The presence of lymph node micrometastasis could predict the survival rate.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 22398863     DOI: 10.1159/000334171

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  6 in total

Review 1.  The lymphatic system and pancreatic cancer.

Authors:  Darci M Fink; Maria M Steele; Michael A Hollingsworth
Journal:  Cancer Lett       Date:  2015-12-29       Impact factor: 8.679

Review 2.  Utility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancer.

Authors:  Xiao-Yi Wang; Feng Yang; Chen Jin; De-Liang Fu
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 3.  Is concomitant radiotherapy necessary with gemcitabine-based chemotherapy in pancreatic cancer?

Authors:  Xin Zhang; He-Jing Huang; Dan Feng; De-Jun Yang; Chang-Ming Wang; Qing-Ping Cai
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

Review 4.  Dilemmas for the pathologist in the oncologic assessment of pancreatoduodenectomy specimens : An overview of different grossing approaches and the relevance of the histopathological characteristics in the oncologic assessment of pancreatoduodenectomy specimens.

Authors:  Eline Soer; Lodewijk Brosens; Marc van de Vijver; Frederike Dijk; Marie-Louise van Velthuysen; Arantza Farina-Sarasqueta; Hans Morreau; Johan Offerhaus; Lianne Koens; Joanne Verheij
Journal:  Virchows Arch       Date:  2018-03-27       Impact factor: 4.064

5.  Pathomorphological features of metastatic lymph nodes as predictors of postoperative prognosis in pancreatic cancer.

Authors:  Mayumi Hoshikawa; Sho Ogata; Makoto Nishikawa; Akifumi Kimura; Takahiro Einama; Takuji Noro; Suefumi Aosasa; Kazuo Hase; Hironori Tsujimoto; Hideki Ueno; Junji Yamamoto
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

Review 6.  Application and progress of medical imaging in total mesopancreas excision for pancreatic head carcinoma.

Authors:  Pei Feng; Bo Cheng; Zhen-Dong Wang; Jun-Gui Liu; Wei Fan; Heng Liu; Chao-Ying Qi; Jing-Jing Pan
Journal:  World J Gastrointest Surg       Date:  2021-11-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.